Akumin DSO Ratio 2011-2026 | AKU

Annual DSO Ratio Akumin

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
57.4	79.7	85.9	44	70.3	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
85.9	44	67.4

Quarterly DSO Ratio Akumin

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
59.1	56.9	55.7	-	58.3	60	60.8	-	57	-	44.4	11.6	-	-	-	11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
60.8	11	47.5

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 202.18	-0.43 %	$ 22.4 B	USA
Co-Diagnostics CODX	94.7	$ 3.78	-11.89 %	$ 5.03 M	USA
Fulgent Genetics FLGT	87	$ 18.35	-1.77 %	$ 565 M	USA
Castle Biosciences CSTL	50.2	$ 20.66	-0.19 %	$ 599 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	72.7	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Guardant Health GH	46.1	$ 129.82	-1.37 %	$ 16.3 B	USA
Interpace Biosciences IDXG	66.9	$ 1.58	-1.56 %	$ 6.99 M	USA
CareDx, Inc CDNA	51.5	$ 24.08	4.83 %	$ 1.28 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Illumina ILMN	66.8	$ 166.89	3.68 %	$ 25.9 B	USA
ICON Public Limited Company ICLR	63.4	$ 147.72	1.05 %	$ 11.6 B	Irlanda
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Mettler-Toledo International MTD	66.4	$ 1 154.47	2.03 %	$ 23.8 B	Schweiz
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
National Research Corporation NRC	29.4	$ 18.31	-2.55 %	$ 410 M	USA
Natera NTRA	48.3	$ 216.97	2.31 %	$ 29.7 B	USA
Lantheus Holdings LNTH	80.5	$ 104.67	0.14 %	$ 7.06 B	USA
Charles River Laboratories International CRL	65	$ 188.47	0.51 %	$ 9.34 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	71.8	$ 1.32	0.76 %	$ 396 M	USA
Medpace Holdings MEDP	50.4	$ 467.5	0.03 %	$ 13.5 B	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
NeoGenomics NEO	77.7	$ 11.09	-0.54 %	$ 1.42 B	USA
Myriad Genetics MYGN	52.3	$ 4.32	-0.23 %	$ 400 M	USA
Personalis PSNL	63.8	$ 9.79	2.09 %	$ 874 M	USA
Senseonics Holdings SENS	1.04	$ 7.24	0.84 %	$ 302 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	27	-	-	$ 2.69 B	USA
Biomerica BMRA	57.7	$ 2.0	-2.44 %	$ 4.59 M	USA
Twist Bioscience Corporation TWST	44.5	$ 80.79	6.07 %	$ 4.83 B	USA
Laboratory Corporation of America Holdings LH	52.9	$ 265.03	-0.42 %	$ 22.1 B	USA
Thermo Fisher Scientific TMO	70	$ 473.72	1.03 %	$ 179 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.68	4.18 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	66.6	$ 9.3	2.2 %	$ 2.02 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA